DL Global Partners Inc. Led by Edward M. Sellers, MD, PhD, FRCPC, FACP, a highly respected authority in the industry, DL Global Partners offers a wide range of products and services designed to accelerate early stage drug development and optimize strategies for assessing the abuse potential of new drugs.

With over 40 years of experience and more than 380 published papers, Dr. Sellers has established himself as a leader in the field. The company also boasts Myroslava K.

Romach, MSc, MD, FRCPC, a psychiatrist and industry executive with over 25 years of experience in drug development. Together, they bring a deep understanding of clinical psychopharmacology and mental health to DL Global Partners. The brand's expertise extends to various areas, including regulatory risk management and the application of abuse liability methodology to modified risk tobacco products.

With a focus on providing innovative solutions to academic institutions, hospitals, government agencies, and biopharmaceutical companies, DL Global Partners is dedicated to advancing the field of clinical psychopharmacology and driving positive change in drug development